Altered chaperone-nonmuscle myosin II interactions drive pathogenicity of the UNC45A c.710T>C variant in osteo-oto-hepato-enteric syndrome.
Waich S. et al, (2025), JCI insight, 10
Upadacitinib for Induction of Remission in Paediatric Crohn's Disease: An International Multicentre Retrospective Study.
Cohen S. et al, (2025), Alimentary pharmacology & therapeutics
Effectiveness and Safety of Adalimumab in Patients With Very Early-Onset Inflammatory Bowel Disease: A Retrospective Study on Behalf of the Porto Inflammatory Bowel Disease Working Group of European Society for Pediatric Gastroenterology Hepatology and Nutrition.
Weintraub Y. et al, (2025), Inflammatory bowel diseases
Upadacitinib for Induction of Remission in Pediatric Ulcerative Colitis: An International Multi‑center Study.
Yerushalmy-Feler A. et al, (2024), J Crohns Colitis
A longitudinal single-cell atlas of anti-tumour necrosis factor treatment in inflammatory bowel disease.
Thomas T. et al, (2024), Nature immunology, 25, 2152 - 2165
The circulating methylome in childhood-onset inflammatory bowel disease.
Noble A. et al, (2024), Journal of Crohn's & colitis
Biallelic PI4KA Mutations Disrupt B-Cell Metabolism and Cause B-Cell Lymphopenia and Hypogammaglobulinemia.
Saettini F. et al, (2024), Journal of clinical immunology, 45
Successful Allogeneic Hematopoietic Cell Transplantation for Patients with IL10RA Deficiency in Japan.
Tomomasa D. et al, (2024), Journal of clinical immunology, 45
Cellular and molecular basis of proximal small intestine disorders.
Bildstein T. et al, (2024), Nature reviews. Gastroenterology & hepatology
Neutralizing Autoantibodies against Interleukin-10 in Inflammatory Bowel Disease.
Griffin H. et al, (2024), The New England journal of medicine, 391, 434 - 441
Short-chain fatty acids: linking diet, the microbiome and immunity.
Mann ER. et al, (2024), Nature reviews. Immunology, 24, 577 - 595
Intestinal Inflammation and Extraintestinal Disease: Understanding Dynamic Risk.
Ashton JJ. et al, (2024), Gastroenterology, 167, 205 - 208
Identification and validation of a blood- based diagnostic lipidomic signature of pediatric inflammatory bowel disease.
Salihovic S. et al, (2024), Nature communications, 15
An isoform quantitative trait locus in SBNO2 links genetic susceptibility to Crohn's disease with defective antimicrobial activity.
Aschenbrenner D. et al, (2024), Nature communications, 15
The impact of inversions across 33,924 families with rare disease from a national genome sequencing project
Pagnamenta AT. et al, (2024), The American Journal of Human Genetics
Genomic Testing Identifies Monogenic Causes in Patients with Very Early-Onset Inflammatory Bowel Disease: A Multi-center Survey in an Iranian Cohort.
Eslamian G. et al, (2024), Clinical and experimental immunology
Structural and non-coding variants increase the diagnostic yield of clinical whole genome sequencing for rare diseases
Pagnamenta AT. et al, (2023), Genome Medicine, 15
Author Correction: Inflammation across tissues: can shared cell biology help design smarter trials?
Hosack T. et al, (2023), Nature reviews. Rheumatology
Precision medicine in monogenic inflammatory bowel disease: proposed mIBD REPORT standards.
Uhlig HH. et al, (2023), Nature reviews. Gastroenterology & hepatology
Inflammation across tissues: can shared cell biology help design smarter trials?
Hosack T. et al, (2023), Nature reviews. Rheumatology